Back to Search
Start Over
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
- Source :
-
Bone marrow transplantation [Bone Marrow Transplant] 2022 Mar; Vol. 57 (3), pp. 499-501. Date of Electronic Publication: 2022 Jan 10. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1476-5365
- Volume :
- 57
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Bone marrow transplantation
- Publication Type :
- Editorial & Opinion
- Accession number :
- 35013536
- Full Text :
- https://doi.org/10.1038/s41409-021-01560-y